Roche’s First Quarter Sales 2019

Audio Webcast and Conference Call, 17 April 2019

Investor updates

All

Published on: 18 March 2019

Invitation to Roche's First Quarter Sales 2019 Audio Webcast and Conference Call

more

Published on: 18 March 2019

Roche to present results of the largest safety study of its kind with Tecentriq (atezolizumab) in patients with metastatic bladder cancer

more

Published on: 15 March 2019

European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease

more

IR events

All

21March

20th Kepler Cheuvreux Swiss Seminar

(CET)

Zurich, Switzerland

add to calendar

17April

Roche 1st Quarter 2019 Conference Call

(CEST)

Basel, Switzerland

more add to calendar

14May

Berenberg Diagnostics Conference 2019

(GMT)

London, UK

add to calendar

Share price

Latest annual report

Annual Report 2018 Highlights

How digital innovation increases patient benefit in the future

more

Finance information tool

more

Pipeline

Pipeline

Get up-to-date information about our pipeline.

more

Roche R&D

more

Genentech Biooncology

more

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

more

Sustainability

Sustainability download center

more

Sustainability at Roche

more

Non-financial reporting

more

Dividend and total return

Dividend calendar

Timetable for payment of the 2018 dividend

more

Total return center

Investor tool providing analysis of total returns

more

Additional share data

FAQ

Get answers to frequently asked questions

more

US investors

How to invest

more

poster

Message from our CEO

“The foundation of our success is and will remain our clear focus on innovation.”

Contact